In order to maintain a good performance in the stock market, the only way to inject the high-quality assets of Changda Group is to inject the high-quality assets of Changda Group as soon as possible, but before injecting assets, Guan Yuntian suggested that the listed company should change its name first.

Changda Group is not familiar enough with the relevant procedures, otherwise, after the completion of the reorganization, the backdoor listing will be successful, and the name change can be announced at that time according to the regulations. Now this matter has to be discussed by the board of directors, but fortunately, this matter is only beneficial to the interests of shareholders, without any damage, and under the auspices of Ye Jiayi, it was easily approved.

The renamed listed company is called "Changda Holdings", which was announced by the original Xinrui Pharmaceutical Co., Ltd. after filing with the regulatory authorities and the stock trading market, and officially debuted on the first trading day of the second week.

Subsequently, the new major shareholder proposed to inject 5 billion yuan of high-quality assets of Changda Group into the listed company, but was opposed by retail representatives, who argued that the injected assets were too large and their shares were diluted several times.

Of course, this matter is not represented by retail investors, and the purpose of Changda Group to seek listing in every possible way is to push its own assets to the stock market.

According to the equity structure of the original Xinrui Pharmaceutical Company, Changda Group holds 65% of the additional issuance, and the remaining 35% is for other shareholders to repurchase and trade in the secondary market.

After the additional issuance, Changda Group holds more than 65% of the shares in the listed company, and the shareholders of Xinrui Pharmaceutical have also held 11% of the shares through repurchase, and is still the second largest shareholder of Changda Holdings.

Seeing the funds raised by the additional stock issuance, Lao Li, the shareholder representative of Xinrui Pharmaceutical, called Guan Yuntian, "Mr. Guan, I am Lao Li of Xinrui Pharmaceutical, and I want to discuss one thing with you." ”

"Mr. Li, may I ask what you are doing?"

"Didn't we discuss it before, and after the restructuring is completed, we will consider drug advertising and promotion. Now not only has the restructuring been completed, but the listed company has also changed its name, and after the asset injection of Changda Group, a lot of funds have been raised through the issuance of shares.

"Mr. Li, this is a matter of Changda Holdings, a listed company, and it has nothing to do with me, you should discuss this matter with your chairman Mr. Ye. "Guan Yuntian said.

"Ouch, I'm also from here, don't push it in front of me, you are the chairman of Changda Group, and Mr. Ye has to listen to you in the end. So, consult with you directly to avoid the need for more procedures. ”

Lao Li is right, but things can't be done like this, you, Lao Li, are only a member of the board of directors of Changda Holdings, and Xinrui Pharmaceutical is only a subsidiary of Changda Holdings.

"Mr. Li, when it comes to the rules and procedures of listed companies, you are a teacher and a senior, I think that the matter of Changda Holdings should be discussed in your board of directors, and you should take the lead in setting an example in this regard! Guan Yuntian's words can be described as soft and rigid.

Lao Li hit a soft nail, and he had to say stupidly, "You're right, it should be discussed in the board of directors." ”

Ending the call with Guan Yuntian, Lao Li dialed Ye Jiayi's phone again, "Mr. Ye, I am Lao Li of Xinrui Pharmaceutical." ”

"Hello Mr. Li, what's the matter with you?"

"We're new

(This chapter is not finished, please turn the page)

The promotion of Rui Pharmaceutical's products was raised in the process of restructuring negotiations, and it was agreed by Mr. Guan and Mr. Ding of Changda Group at that time.

"Mr. Li, I'm really sorry, I haven't heard them talk about this, if they agree, they should be supported. Otherwise, I'll find out about the situation and I'll get back to you later. ”

Ye Jiayi asked Guan Yuntian about the situation, Guan Yuntian told her that this matter was indeed mentioned during the restructuring process, but did not give any promise to the other party, and the reply at that time was to make a decision on whether to support or not after demonstrating its efficacy.

Ye Jiayi dialed Lao Li's phone, "Mr. Li, I have already understood the situation, you can send me the materials of the clinical trial, if it is confirmed that there is indeed a curative effect, there is no need for the board of directors to discuss, isn't it just the advertising of the drug? ”

"This ----, clinical experiment data is in the Provincial Institute of Traditional Chinese Medicine, not in our hands, I'm afraid it's a bit difficult!" Lao Li felt embarrassed.

"What's the trouble with this? At that time, you were spending money to introduce technology, right? The other party should hand over the clinical trial data to you without reservation, without spending a penny, if you don't come, we can ask the other party in the name of Changda Holdings." "Ye Jiayi is a person who has seen the world, and she is not afraid at all to deal with such a problem.

"Mr. Ye, I'll ask about the situation first, and then I'll contact you. ”

Lao Li immediately contacted the Provincial Institute of Traditional Chinese Medicine, and the other party told him that because of the long time, it was difficult to find clinical trial data, which made Lao Li very anxious, but he had no other way.

Ye Jiayi thinks that things are not so complicated, as a clinical trial data of a drug, although it takes a little longer, but it is only seven or eight years, such an important technical document, the Institute of Chinese Medicine must have archives, how can it not be found? There must be something strange in it. Ye Jiayi discussed with Guan Yuntian and decided to send a lawyer's letter to the Institute of Chinese Medicine in the name of Changda Holdings.

Lawyer Zhao has been the perennial legal counsel of Changda Group, after the restructuring of Xinrui Pharmaceutical, his legal team has now become the legal counsel of Changda Holdings, Ye Jiayi explained the situation to Lawyer Zhao, "It is the technical information purchased by the original Xinrui Pharmaceutical Company, which is part of the technology transfer, and we hope to get it back, even if it is a copy." ”

"Mr. Ye, we are responsible for legal affairs, I will immediately arrange for someone to send a lawyer's letter to the other party, but you'd better let Xinrui Pharmaceutical find out the invoices or receipts of previous payments, if the Institute of Traditional Chinese Medicine ignores our lawyer's letter, then we can only take legal action, and then the payment receipt or invoice for technology transfer is evidence." In addition, ask Xinrui Pharmaceutical Company to fax the technology transfer contract or agreement signed at that time in case of emergency. ”

Ye Jiayi fed back the situation to Mr. Li of Xinrui Pharmaceutical, "The purpose of this is completely for the sake of product consideration, once the efficacy of the drug is confirmed, Changda Holdings will invest heavily in advertising, and if the market prospect is good, it can also invest in expanding production." Ye Jiayi explained.

"Mr. Ye, how do you need us to cooperate, please just ask. Lao Li is indeed a person who wants to do things, as long as he can bring to the market the drugs they have put a lot of effort into to market, he is willing to cooperate unconditionally with the board of directors of the new company.

"Please find out the technology transfer agreement at the time and fax it, and in addition, find the payment receipt or invoice for the technology transfer, and we will handle other things. ”

A week has passed, and there is still no news, Ye Jiayi suggested to Lawyer Zhao that let

(This chapter is not finished, please turn the page)

They sent someone to make a special trip to the Institute of Traditional Chinese Medicine to negotiate with the other party in person.

Lawyer Zhao took an assistant to the Institute of Traditional Chinese Medicine in person, found their foreign cooperation department, and explained their intentions, the other party felt a little incredible, "Changda Holdings is making a bit of a fuss, isn't it just clinical trial data? Why did you send a lawyer? This is a lawsuit!"

"I wonder if you have received a lawyer's letter from us? Let's come and check, but we don't necessarily have to go to court. Lawyer Zhao explained.

"The lawyer's letter has been received, and we don't understand why the other party asked for the technical documents through the lawyer's letter?"

"It is said that Mr. Li of Xinrui Pharmaceutical once called you to ask for it, and only asked us to come forward without getting a response. ”

"We heard that Lao Li's Xinrui Pharmaceutical Company has been merged and reorganized, what does he want to do with this?" the other party said the reason why he did not respond to Lao Li.

"To be precise, it is not Lao Li who asks for this document, but the new company after the reorganization needs this technical information, and we represent Changda Holding Company. Lawyer Zhao said.

"Heck, it's been seven or eight years, and it's hard to find it now. "The other party started to cheat.

"The Provincial Institute of Traditional Chinese Medicine is a very formal scientific research unit, and we believe that such technical documents must be archived, and it should not be difficult to find. It doesn't matter, you guys look slowly, let's find a hotel nearby to stay in and come over every day. ”

Listening to Lawyer Zhao's words, if they don't take this technical information with them, they won't leave, which is completely out of the expectations of the staff of the Foreign Technical Cooperation Department of the Institute of Traditional Chinese Medicine.

In fact, things are quite simple, as Ye Jiayi guessed, the clinical trial data is in the technical filing cabinet, just because the staff feel unprofitable and afraid of trouble, they look for various reasons and do everything possible to shirk it, if Changda Holding Company gives 180,000, the matter will be solved.

However, Changda Holding Company not only did not give a penny, but also sent a lawyer to ask for it, and the staff of the relevant departments of the Institute of Traditional Chinese Medicine could no longer push it off, so the next day they found the clinical trial report, made a copy, and sent Lawyer Zhao and his assistant away.

Ye Jiayi carefully studied the report, consulted relevant experts, and gave the opinion that the composition of the Chinese patent medicine is reasonable, and the clinical trial effect is remarkable, in this case, she believes that it is worth investing in and promoting.

After listening to Ye Jiayi's report, Guan Yuntian said: "During the restructuring negotiations, it was agreed with Lao Li that as long as the efficacy was confirmed, they agreed to advertise the product. ”

The advertising budget of Xinrui Pharmaceutical Branch was presented to Ye Jiayi, and she was a little difficult in the face of this budget report of 20 million. To be honest, for this Chinese patent medicine with an estimated annual output value of 200 million yuan and a profit of less than 30 million, she thinks that the budget is really a bit big to invest 20 million in advertising at a time.

However, the budget report specifically emphasizes that the market size can be doubled in the future as long as the advertising is in place.

Ye Jiayi felt that there were many uncertainties involved, and if the budget report was submitted to the board of directors for discussion, the advertising budget of 20 million would definitely not be approved.

However, Lao Li is very confident in the original product of Xinrui Pharmaceutical, and if he is caught on this issue, if the product is not done well in the future, he will put the responsibility on others. Otherwise, he will agree to their advertising budget as he wishes, and if he does it well, it is within his bounds, and if he doesn't do it well, he can't complain about others.

(End of chapter)